Breakthrough Cryo-EM Structures Expose Multiple Drug Targets in HSV-1 Replication Protein
Researchers from Karolinska Institutet, the University of Gothenburg, and the Centre for Structural Systems Biology in Hamburg have made a groundbreaking discovery in the fight against herpes simplex virus-1 (HSV-1). Using cryo-electron microscopy (cryo-EM), they have captured high-resolution structures of the origin-binding protein (OBP), a critical component of viral DNA replication. The findings, published in Nucleic Acids Research, reveal unexpected mechanisms for how the virus initiates DNA replication and identify multiple promising targets for next-generation antiviral drugs.
Key Takeaways:
- The research team captured high-resolution structures of the OBP protein using cryo-EM at resolutions up to 2.8 Å.
- The structures show the protein in multiple functional states, including bound to viral DNA origin sequences and complexed with an ATP analogue.
- The OBP protein represents a new target for antiviral treatments, acting earlier in the viral lifecycle than current HSV-1 treatments.
- The structures reveal a unique regulatory mechanism where the extreme C-terminus of each protein molecule threads through its partner, positioning itself near the ATP-binding pocket.
- The helicase activity of OBP is regulated by the C-terminus, which acts as an intrinsic brake on helicase activity.
- Multiple potential sites for antiviral drug development have been identified, including the DNA-binding motif, the dimer interface, and the ICP8-binding region.
- The findings provide a molecular blueprint for drug design and could help overcome resistance mechanisms and prevent viral reactivation from latency.
- The research has significant implications for cancer patients undergoing chemotherapy or bone marrow transplantation, where treatment-induced immune suppression frequently triggers reactivation of latent herpesviruses.
Statistics:
- 70% of the global population carries HSV-1 with symptoms ranging from cold sores to potentially fatal encephalitis (Source: Karolinska Institutet).
- 2.8 Å is the highest resolution achieved in the cryo-EM structures (Source: Karolinska Institutet).
- Multiple promising targets for next-generation antiviral drugs have been identified, including the DNA-binding motif, the dimer interface, and the ICP8-binding region (Source: Karolinska Institutet).
Sources:
- Karolinska Institutet
- Nucleic Acids Research
- Swedish Research Council
- Swedish Cancer Foundation
- Helmholtz Association